Breast nodule classification with two-dimensional ultrasound using Mask-RCNN ensemble aggregation.

Artificial intelligence Breast neoplasms, Deep learning Neural network Ultrasound

Journal

Diagnostic and interventional imaging
ISSN: 2211-5684
Titre abrégé: Diagn Interv Imaging
Pays: France
ID NLM: 101568499

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 14 04 2021
revised: 10 09 2021
accepted: 10 09 2021
pubmed: 4 10 2021
medline: 23 11 2021
entrez: 3 10 2021
Statut: ppublish

Résumé

The purpose of this study was to create a deep learning algorithm to infer the benign or malignant nature of breast nodules using two-dimensional B-mode ultrasound data initially marked as BI-RADS 3 and 4. An ensemble of mask region-based convolutional neural networks (Mask-RCNN) combining nodule segmentation and classification were trained to explicitly localize the nodule and generate a probability of the nodule to be malignant on two-dimensional B-mode ultrasound. These probabilities were aggregated at test time to produce final results. Resulting inferences were assessed using area under the curve (AUC). A total of 460 ultrasound images of breast nodules classified as BI-RADS 3 or 4 were included. There were 295 benign and 165 malignant breast nodules used for training and validation, and another 137 breast nodules images used for testing. As a part of the challenge, the distribution of benign and malignant breast nodules in the test database remained unknown. The obtained AUC was 0.69 (95% CI: 0.57-0.82) on the training set and 0.67 on the test set. The proposed deep learning solution helps classify benign and malignant breast nodules based solely on two-dimensional ultrasound images initially marked as BIRADS 3 and 4.

Identifiants

pubmed: 34600861
pii: S2211-5684(21)00200-X
doi: 10.1016/j.diii.2021.09.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

653-658

Informations de copyright

Copyright © 2021 Société française de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Ewan Evain (E)

Philips Research France, 92150 Suresnes, France; University of Lyon, CREATIS, CNRS UMR5220, Inserm U1044, INSA-Lyon, University of Lyon 1, 69100 Villeurbanne, France. Electronic address: ewan.evain@philips.com.

Caroline Raynaud (C)

Philips Research France, 92150 Suresnes, France.

Cybèle Ciofolo-Veit (C)

Philips Research France, 92150 Suresnes, France.

Alexandre Popoff (A)

Philips Research France, 92150 Suresnes, France.

Thomas Caramella (T)

Riviera Imagerie Médicale, 06800 Cagnes-sur-Mer, France.

Pascal Kbaier (P)

Centre d'Imagerie Médicale Toulon Hyeres Littoral, 83000 Toulon, France.

Corinne Balleyguier (C)

Department of Medical Imaging, Institut Gustave Roussy, 94800 Villejuif, France; Laboratoire d'Imagerie Biomédicale Multimodale Paris-Saclay. BIOMAPS, UMR 1281. Université Paris-Saclay, Inserm, CNRS, CEA, 94805 Villejuif, France.

Sana Harguem-Zayani (S)

Department of Medical Imaging, Institut Gustave Roussy, 94800 Villejuif, France.

Héloïse Dapvril (H)

Department of Women's Imaging, CH de Valenciennes, 59300 Valenciennes, France.

Luc Ceugnart (L)

Department of Radiology, Centre Oscar Lambret, 59000 Lille, France.

Michele Monroc (M)

Department of Radiology, Clinique Saint-Antoine, 76230 Bois-Guillaume, France.

Foucauld Chamming's (F)

Department of Radiology, Institut Bergonié, 33000 Bordeaux, France.

Isabelle Doutriaux-Dumoulin (I)

Department of Radiology, Institut de Cancérologie de l'Ouest, 44800 Saint-Herblain, France.

Isabelle Thomassin-Naggara (I)

Department of Radiology, Centre Intercommunal de Créteil, 94000 Créteil, France.

Audrey Haquin (A)

Department of Radiology, Hôpital Croix Rousse, 69000 Lyon, France.

Mathilde Charlot (M)

Department of Radiology, CH Lyon Sud, 69000 Lyon, France.

Joseph Orabona (J)

Department of Radiology, CH de Bastia, 20200 Bastia, France.

Tiphaine Fourquet (T)

Department of Radiology, CHRU Lille, 59000 Lille, France.

Imad Bousaid (I)

Département de la Transformation Numérique et du Système d'Information, Gustave-Roussy Cancer Campus, Université Paris-Saclay, 94805 Villejuif, France.

Nathalie Lassau (N)

Laboratoire d'Imagerie Biomédicale Multimodale Paris-Saclay. BIOMAPS, UMR 1281. Université Paris-Saclay, Inserm, CNRS, CEA, 94805 Villejuif, France; Department of Medical Imaging, Institut Gustave Roussy, 94800 Villejuif, France.

Antoine Olivier (A)

Philips Research France, 92150 Suresnes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH